Nihon Kohden
Nihon Kohden Corporation, a leading name in the medical technology industry, is headquartered in Japan (JP) and operates extensively across Asia, Europe, and the Americas. Founded in 1951, the company has established itself as a pioneer in the development of innovative medical devices and solutions, particularly in the fields of patient monitoring, electrophysiology, and neurodiagnostics. Nihon Kohden's core products include advanced patient monitors, electrocardiographs, and EEG systems, all designed to enhance clinical efficiency and patient care. The company is renowned for its commitment to quality and innovation, which has earned it a strong market position and numerous accolades within the healthcare sector. With a focus on integrating cutting-edge technology and user-friendly design, Nihon Kohden continues to set benchmarks in medical instrumentation, making significant contributions to global healthcare advancements.
DitchCarbon Score
How does Nihon Kohden's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Nihon Kohden's score of 38 is higher than 65% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Nihon Kohden's reported carbon emissions
In 2023, Nihon Kohden reported total carbon emissions of approximately 7,894,000 kg CO2e, a decrease from about 9,367,000 kg CO2e in 2022. The emissions breakdown for 2023 includes about 4,250,000 kg CO2e from Scope 1 and approximately 3,644,000 kg CO2e from Scope 2. This trend indicates a commitment to reducing their carbon footprint, although specific reduction targets or initiatives have not been disclosed. The company has consistently reported emissions data for Scope 1 and Scope 2 over the past few years, with 2021 emissions at about 10,171,000 kg CO2e and 2020 emissions at approximately 12,294,000 kg CO2e. Despite the lack of Scope 3 emissions data, Nihon Kohden's efforts reflect an ongoing focus on sustainability within the medical technology sector. Nihon Kohden has not set specific science-based targets or climate pledges, but their emissions reductions over the years suggest a proactive approach to climate commitments. The data is not cascaded from any parent organization, indicating that these figures are independently reported by Nihon Kohden Corporation.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|
| Scope 1 | 4,684,000 | 0,000,000 | 0,000,000 | 0,000,000 |
| Scope 2 | 7,610,000 | 0,000,000 | 0,000,000 | 0,000,000 |
| Scope 3 | - | - | - | - |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Nihon Kohden is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
